Literature DB >> 8939170

Bronchial biopsy findings in intermittent or "early" asthma.

L A Laitinen1, A Laitinen, A Altraja, I Virtanen, M Kämpe, B G Simonsson, S E Karlsson, L Håkansson, P Venge, H Sillastu.   

Abstract

Bronchial biopsy specimens from subjects with intermittent or "early" asthma were compared with specimens taken from healthy subjects. Patients with early asthma included those with seasonal asthma and occupational asthma. There was a small but statistically significant increase in the thickness of the subepithelial extracellular matrix protein tenascin in subjects with seasonal and occupational asthma compared with control subjects. Collagen types IV and VII were increased only in patients with occupational asthma. Eosinophils were the only inflammatory cells that were significantly increased in subjects with seasonal asthma compared with control subjects. These data show that inflammation is present in the airways of patients with early asthma, and the increase in tenascin expression in the basement membrane zone suggests that structural changes are also initiated at an early stage of the disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8939170

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  13 in total

Review 1.  Airway smooth muscle and fibroblasts in the pathogenesis of asthma.

Authors:  Peter R A Johnson; Janette K Burgess
Journal:  Curr Allergy Asthma Rep       Date:  2004-03       Impact factor: 4.806

2.  Extracellular 14-3-3 from human lung epithelial cells enhances MMP-1 expression.

Authors:  Negar Asdaghi; Ruhangiz T Kilani; Azadeh Hosseini-Tabatabaei; Solomon O Odemuyiwa; Tillie-Louise Hackett; Darryl A Knight; Aziz Ghahary; Redwan Moqbel
Journal:  Mol Cell Biochem       Date:  2011-09-25       Impact factor: 3.396

3.  Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma.

Authors:  C Ward; M Pais; R Bish; D Reid; B Feltis; D Johns; E H Walters
Journal:  Thorax       Date:  2002-04       Impact factor: 9.139

4.  Roxithromycin, clarithromycin, and azithromycin attenuate the injurious effects of bioactive phospholipids on human respiratory epithelium in vitro.

Authors:  C Feldman; R Anderson; A J Theron; G Ramafi; P J Cole; R Wilson
Journal:  Inflammation       Date:  1997-12       Impact factor: 4.092

5.  Targeting integrin α5β1 ameliorates severe airway hyperresponsiveness in experimental asthma.

Authors:  Aparna Sundaram; Chun Chen; Amin Khalifeh-Soltani; Amha Atakilit; Xin Ren; Wenli Qiu; Hyunil Jo; William DeGrado; Xiaozhu Huang; Dean Sheppard
Journal:  J Clin Invest       Date:  2016-12-05       Impact factor: 14.808

6.  Population based study of risk factors for underdiagnosis of asthma in adolescence: Odense schoolchild study.

Authors:  H C Siersted; J Boldsen; H S Hansen; G Mostgaard; N Hyldebrandt
Journal:  BMJ       Date:  1998-02-28

Review 7.  Airway smooth muscle in asthma: just a target for bronchodilation?

Authors:  Judith L Black; Reynold A Panettieri; Audreesh Banerjee; Patrick Berger
Journal:  Clin Chest Med       Date:  2012-07-11       Impact factor: 2.878

8.  Real-time assessment of inflammation and treatment response in a mouse model of allergic airway inflammation.

Authors:  Virna Cortez-Retamozo; Filip K Swirski; Peter Waterman; Hushan Yuan; Jose Luiz Figueiredo; Andita P Newton; Rabi Upadhyay; Claudio Vinegoni; Rainer Kohler; Joseph Blois; Adam Smith; Matthias Nahrendorf; Lee Josephson; Ralph Weissleder; Mikael J Pittet
Journal:  J Clin Invest       Date:  2008-11-06       Impact factor: 14.808

9.  The Role of the T lymphocytes and Remodeling in Asthma.

Authors:  Kawa Amin
Journal:  Inflammation       Date:  2016-08       Impact factor: 4.092

10.  Reticular basement membrane in asthma and COPD: similar thickness, yet different composition.

Authors:  Jeroen J W Liesker; Nick H Ten Hacken; Mieke Zeinstra-Smith; Steven R Rutgers; Dirkje S Postma; Wim Timens
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.